ADIAL PHARMACEUTICALS INC (ADIL)
US00688A2050 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -7.00M | -12.73M | -19.42M | -10.89M | -8.59M | |||
| Depreciation Amortization | 560.00 | 10.00K | 10.00K | 0.00 | 0.00 | |||
| Income Taxes - Deferred | N/A | 0.00 | -90.00K | N/A | N/A | |||
| Change In Working Capital | -794.21K | -1.37M | 1.47M | 1.25M | 210.00K | |||
| Interest Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Taxes Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other non cash items | 988.72K | 2.90M | 6.09M | 2.01M | 2.04M | |||
| OPERATING CASH FLOW | -6.81M | -11.19M | -11.95M | -7.63M | -6.34M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | 0.00 | -60.00K | N/A | N/A | |||
| Other Investing Activity | 1.50M | 0.00 | 30.00K | -350.00K | N/A | |||
| INVESTING CASH FLOW | 1.50M | 0.00 | -30.00K | -350.00K | N/A | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | 0.00 | |||
| Stock Issued/Repurchased | 4.13M | 9.13M | 13.64M | 5.61M | 9.25M | |||
| FINANCING CASH FLOW | 4.13M | 9.13M | 13.64M | 5.61M | 9.25M | |||
| CHANGE IN CASH | -1.17M | -2.06M | 1.66M | -2.37M | 2.91M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -6.81M | -11.19M | -11.95M | -7.63M | -6.34M | |||
| Capital Expenditure | N/A | 0.00 | -60.00K | N/A | N/A | |||
| FREE CASH FLOW | -6.81M | -11.19M | -12.01M | -7.63M | -6.34M | |||
All data in USD